BRPI0414455A - métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins - Google Patents

métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins

Info

Publication number
BRPI0414455A
BRPI0414455A BRPI0414455-4A BRPI0414455A BRPI0414455A BR PI0414455 A BRPI0414455 A BR PI0414455A BR PI0414455 A BRPI0414455 A BR PI0414455A BR PI0414455 A BRPI0414455 A BR PI0414455A
Authority
BR
Brazil
Prior art keywords
methods
vascular disease
peripheral vascular
adipose tissue
related disorders
Prior art date
Application number
BRPI0414455-4A
Other languages
English (en)
Inventor
John K Fraser
Marc H Hedrick
Eric Daniels
Original Assignee
Macropore Biosurgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macropore Biosurgery Inc filed Critical Macropore Biosurgery Inc
Publication of BRPI0414455A publication Critical patent/BRPI0414455A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"MéTODOS PARA USAR CéLULAS REGENERATIVAS NO TRATAMENTO DE DOENçA VASCULAR PERIFéRICA E DISTúRBIOS AFINS". Células presentes em tecido adiposo são usadas para tratar pacientes, incluindo pacientes com doença vascular periférica (PVD) e doenças e distúrbios afins. Os métodos para tratar os pacientes incluem processar tecido adiposo para distribuir uma quantidade concentrada de células-tronco, obtidas a partir do tecido adiposo, para um paciente. Os métodos podem ser praticados em um sistema fechado, de tal modo que as células-tronco não sejam expostas a um ambiente externo antes de serem administradas a um paciente. Conseqüentemente, em um método preferido, as células presentes no tecido adiposo são colocadas diretamente dentro de um recipiente, junto com os aditivos necessários para promover, produzir ou sustentar um benefício terapêutico.
BRPI0414455-4A 2003-09-17 2004-07-01 métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins BRPI0414455A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50358903P 2003-09-17 2003-09-17
PCT/US2004/021480 WO2005034843A2 (en) 2003-09-17 2004-07-01 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders

Publications (1)

Publication Number Publication Date
BRPI0414455A true BRPI0414455A (pt) 2006-11-14

Family

ID=34434859

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414455-4A BRPI0414455A (pt) 2003-09-17 2004-07-01 métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins

Country Status (11)

Country Link
EP (2) EP2348103B1 (pt)
JP (1) JP5019511B2 (pt)
CN (1) CN1878470A (pt)
AU (1) AU2004280149A1 (pt)
BR (1) BRPI0414455A (pt)
CA (1) CA2539346A1 (pt)
DK (2) DK1670315T3 (pt)
ES (1) ES2633604T3 (pt)
MX (1) MXPA06003088A (pt)
SG (1) SG146666A1 (pt)
WO (1) WO2005034843A2 (pt)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US20050048035A1 (en) 2001-12-07 2005-03-03 Fraser John K. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
KR100930139B1 (ko) 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US7514075B2 (en) 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7595043B2 (en) 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP1765980A4 (en) * 2004-07-02 2007-12-12 Cytori Therapeutics Inc SYSTEMS AND METHOD FOR THE INSULATION AND USE OF CLINICALLY SAFE, FAT-GUN-GENERATING REGENERATIVE CELLS
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
WO2006086201A2 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
EP2666494B1 (en) 2005-02-07 2018-01-17 Hanuman LLC Platelet rich plasma concentrate apparatus and method
US7789872B2 (en) 2005-03-23 2010-09-07 Shippert Ronald D Tissue transplantation method and apparatus
US7794449B2 (en) 2005-03-23 2010-09-14 Shippert Ronald D Tissue transplantation method and apparatus
US7780649B2 (en) 2005-03-23 2010-08-24 Shippert Ronald D Tissue transplantation method and apparatus
US8062286B2 (en) 2005-03-23 2011-11-22 Shippert Ronald D Tissue transplantation method and apparatus
US8622997B2 (en) 2005-03-23 2014-01-07 Ronald D. Shippert Tissue transfer method and apparatus
US9581942B1 (en) 2005-03-23 2017-02-28 Shippert Enterprises, Llc Tissue transfer method and apparatus
AU2013216683B2 (en) * 2005-05-25 2016-06-23 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
DE602005026724D1 (de) * 2005-05-25 2011-04-14 Cytori Therapeutics Inc Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leiden
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
KR20080103637A (ko) * 2007-05-25 2008-11-28 주식회사 알앤엘바이오 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물
JP5196890B2 (ja) * 2007-06-29 2013-05-15 オリンパス株式会社 有核細胞回収装置および有核細胞の回収方法
KR20140107677A (ko) 2007-09-19 2014-09-04 플루리스템 리미티드 지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
PL2259774T3 (pl) 2008-02-27 2013-04-30 Biomet Biologics Llc Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
CA2760574C (en) 2009-05-01 2020-10-27 Cytori Therapeutics, Inc. Device and method for preparing tissue for an adipose graft
JP5431786B2 (ja) * 2009-05-12 2014-03-05 國立中央大學 造血幹細胞を単離、生体外（ｅｘｖｉｖｏ）増殖および回収するためのシステムおよび方法
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US8887770B1 (en) 2011-03-17 2014-11-18 Ronald D. Shippert Vessel fill control method and apparatus
JP5628131B2 (ja) * 2011-10-19 2014-11-19 サイトリ セラピューティクス インコーポレイテッド 心血管状態の治療において脂肪組織由来細胞を使用する方法
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9468709B2 (en) 2012-11-12 2016-10-18 Shippert Enterprises, Llc Syringe fill method and apparatus
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9580678B2 (en) 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device
WO2015149098A1 (de) 2014-03-31 2015-10-08 Liporegena Gmbh Vorrichtung zur entnahme und portionierung von fettgewebe
US10772997B2 (en) 2014-05-15 2020-09-15 Ronald D. Shippert Tissue parcelization method and apparatus
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
CA2994279A1 (en) 2015-08-04 2017-02-09 Duke University Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same
US11752213B2 (en) 2015-12-21 2023-09-12 Duke University Surfaces having reduced non-specific binding and antigenicity
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
JP7372736B2 (ja) * 2016-02-16 2023-11-01 ロート製薬株式会社 脂肪組織由来間質細胞を含む虚血性疾患治療剤およびその製造方法
WO2017210476A1 (en) 2016-06-01 2017-12-07 Duke University Nonfouling biosensors
BR112018075194B1 (pt) 2016-06-08 2023-01-10 The Regents Of The University Of California Método e dispositivo para processar amostras
JP2020500150A (ja) 2016-09-23 2020-01-09 デューク ユニバーシティ 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
US11648200B2 (en) 2017-01-12 2023-05-16 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
WO2018213320A1 (en) 2017-05-15 2018-11-22 Duke University Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
US11680083B2 (en) 2017-06-30 2023-06-20 Duke University Order and disorder as a design principle for stimuli-responsive biopolymer networks
WO2019054468A1 (ja) * 2017-09-15 2019-03-21 株式会社カネカ 細胞含有試料からの細胞の遊離方法
WO2019147954A1 (en) 2018-01-26 2019-08-01 Duke University Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
US12257308B2 (en) 2018-04-30 2025-03-25 Duke University Stimuli-responsive PEG-like polymer-based drug delivery platform
US11649275B2 (en) 2018-08-02 2023-05-16 Duke University Dual agonist fusion proteins
JP7675649B2 (ja) * 2018-10-25 2025-05-13 エンドロジックス リミテッド ライアビリティ カンパニー 二又ステントグラフト、ステント、および方法
CA3119271A1 (en) * 2018-11-09 2020-05-14 Figene, Llc Means and methods of preventing or reversing aging
US11512314B2 (en) 2019-07-12 2022-11-29 Duke University Amphiphilic polynucleotides
BR112022024667A2 (pt) * 2020-06-05 2022-12-27 Univ Duke Composições e métodos para aumentar enxertos de gordura autólogos
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
JP2026500565A (ja) 2022-12-27 2026-01-07 アヴィータ・メディカル・アメリカズ，リミテッド・ライアビリティ・カンパニー 再生上皮懸濁液の自動調製のためのシステムおよび関連する使用方法
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470307A (en) * 1994-03-16 1995-11-28 Lindall; Arnold W. Catheter system for controllably releasing a therapeutic agent at a remote tissue site
US6238908B1 (en) 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
FR2742662B1 (fr) 1995-12-21 1998-01-23 Centre Nat Rech Scient Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
US6280473B1 (en) 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5919234A (en) 1996-08-19 1999-07-06 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
US6269716B1 (en) 1998-11-18 2001-08-07 Macropore, Inc. High-torque resorbable screws
JP2002510530A (ja) 1998-04-07 2002-04-09 マクロポア インコーポレイテッド 組織案内表面波形部付きのメンブレン
US6001642A (en) 1998-06-29 1999-12-14 Wyle Laboratories, Inc. Life Sciences Bioreactor and cell culturing processes using the bioreactor
RU2306335C2 (ru) * 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
US6653146B1 (en) 1999-11-15 2003-11-25 Chemclean Corporation Bio-burden visualization system
KR100795613B1 (ko) 2000-03-10 2008-01-21 마스트 바이오서저리 아게 반흔 조직을 감쇠시키기 위한 재흡수가능한 미세막
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
AU2002211449A1 (en) 2000-10-04 2002-04-15 James Peter Amis Non-scatterable, radio-opaque marker for medical imaging applications
WO2002081007A2 (en) * 2001-04-09 2002-10-17 Medtronic, Inc. Methods of isolating blood components using a centrifuge and uses thereof
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
KR100930139B1 (ko) * 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US20050250202A1 (en) * 2002-03-19 2005-11-10 March Keith L Adipose stromal stem cells for tissue and vascular modification
AU2003278212B2 (en) * 2002-07-31 2009-07-09 Centre National De La Recherche Scientifique Stem cells derived from adipous tissue and differentiated cells derived from said cells
MXPA05009044A (es) * 2003-02-20 2006-03-17 Macropore Biosurgery Inc Metodos para utilizar celulas derivadas de tejido adiposo en el tratamiento de condiciones cardiovasculares.

Also Published As

Publication number Publication date
DK1670315T3 (en) 2017-08-07
EP2348103B1 (en) 2019-06-19
WO2005034843A3 (en) 2005-06-09
CA2539346A1 (en) 2005-04-21
CN1878470A (zh) 2006-12-13
SG146666A1 (en) 2008-10-30
MXPA06003088A (es) 2006-06-20
ES2633604T3 (es) 2017-09-22
EP2348103A3 (en) 2012-07-11
WO2005034843A2 (en) 2005-04-21
JP2007505904A (ja) 2007-03-15
EP1670315A4 (en) 2006-11-15
JP5019511B2 (ja) 2012-09-05
AU2004280149A1 (en) 2005-04-21
EP2348103A2 (en) 2011-07-27
EP1670315B1 (en) 2017-04-19
DK2348103T3 (da) 2019-09-30
EP1670315A2 (en) 2006-06-21

Similar Documents

Publication Publication Date Title
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
AU2009100401A4 (en) Method of extracting and activating adipose-derived stem cells
IL214373A0 (en) Use of adipose tissue-derived cells in the preparation of a composition for the treatment of cardiovascular diseases
BR0214772A (pt) sistemas e métodos para o tratamento de pacientes com células lipoaspiradas processadas
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
EP2465923A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
EP1692516A4 (en) THERAPY PROCESS
AR109103A1 (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
BRPI0607460A2 (pt) braquiterapia periférica de órgãos protrusos moldáveis
PL1778833T3 (pl) Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
BRPI0517976A (pt) métodos de tratamento
Sandel et al. Microsurgical reconstruction for radiation necrosis: an evolving disease
MA28005A1 (fr) Traitement preoperatoire de la douleur postoperatoire
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
WO2006014162A3 (en) Methods of using regenerative cells in the treatment of renal diseases and disorders
RU2009117809A (ru) Способ лечения вагинальных инфекций
Arunachalam et al. Efficacy of placentrex drug against corneal defects in Mecheri sheep.
MD3356G2 (ro) Metodă de tratament al chistului hidatic hepatic

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.